Selective blockade of A2A receptor protects against neurotoxicity induced by kainic acid in young rats
Cristiani F. Bortolatto
Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil
Search for more papers by this authorCristiano R. Jesse
Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil
Search for more papers by this authorEthel A. Wilhelm
Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil
Search for more papers by this authorCorresponding Author
Cristina W. Nogueira
Correspondence and reprints: [email protected]Search for more papers by this authorCristiani F. Bortolatto
Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil
Search for more papers by this authorCristiano R. Jesse
Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil
Search for more papers by this authorEthel A. Wilhelm
Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil
Search for more papers by this authorCorresponding Author
Cristina W. Nogueira
Correspondence and reprints: [email protected]Search for more papers by this authorAbstract
The aim of this study was to investigate the effect of SCH 58261, a selective adenosine A2A receptor (A2AR) antagonist, on kainic acid (KA)-induced seizures in 21-day-old rats. Rats were pretreated with SCH 58261 (1 or 3 mg/kg) by intraperitoneal (i.p.) route 30 min before KA (10 mg/kg, i.p.) administration. The appearance of clonic seizures, the latency for the onset of the first clonic seizure episode, and the number of deaths induced by KA were evaluated. To test the hypothesis of the oxidative imbalance induced by KA exposure, reactive species (RS) levels, catalase (CAT), glutathione peroxidase (GPx), and glutathione S-transferase (GST) activities in the brains of rats were measured. Both doses of SCH 58261 prolonged the latency for the onset of the first clonic seizure episode. SCH 58261, at the highest dose, decreased the appearance of clonic seizures as well as the mortality rate induced by KA administration. SCH 58261, at the dose of 3 mg/kg, was also effective in protecting against alterations in oxidative stress parameters (RS levels, CAT, GPx, and GST activities) in the brains of young rats exposed to KA. Our data reveal that SCH 58261 was protective against the neurotoxicity induced by KA. Therefore, the blockade of A2AR might represent a novel approach for the treatment of seizures.
References
- 1 Holmes G.L. The 2008 Judith Hoyer lecture: epilepsy in children: listening to mothers. Epilepsy Behav. (2009) 16 193–202.
- 2 Lynch M., Sayin U., Bownds J., Janumpalli S., Sutula T. Long-term consequences of early postnatal seizures on hippocampal learning and plasticity. Eur. J. Neurosci. (2000) 12 2252–2264.
- 3 Sayin U., Sutula T.P., Stafstrom C.E. Seizures in the developing brain cause adverse long-term effects on spatial learning and anxiety. Epilepsia (2004) 45 1539–1548.
- 4 Hermann B., Seidenberg M., Jones J. The neurobehavioural comorbidities of epilepsy: can a natural history be developed? Lancet. Neurol. (2008) 7 151–160.
- 5 Engel J.J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on classification and terminology. Epilepsia (2001) 42 796–803.
- 6 Mathis C., Ungerer A. Comparative analysis of seizures induced by intracerebroventricular administration of NMDA, kainate and quisqualate in mice. Exp. Brain Res. (1992) 88 277–282.
- 7 Holopainen I.E. Seizures in the developing brain: cellular and molecular mechanisms of neuronal damage, neurogenesis and cellular reorganization. Neurochem. Int. (2008) 52 935–947.
- 8 Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience (1985) 14 375–403.
- 9 Ferkany J.W., Zaczek R., Coyle J.T. Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptor. Nature (1982) 298 757–759.
- 10 Li S.Y., Jia Y.H., Sun W.G. et al. Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus. Free Radic. Biol. Med. (2010) 48 597–608.
- 11 Dal-Pizzol F., Klamt F., Vianna M.M. et al. Lipid peroxidation in hippocampus early and late after status epilepticus induced by pilocarpine or kainic acid in Wistar rats. Neurosci. Lett. (2000) 291 179–182.
- 12 Shin E.J., Jeong J.H., Bing G. et al. Kainate-induced mitochondrial oxidative stress contributes to hippocampal degeneration in senescence-accelerated mice. Cell. Signal. (2008) 20 645–658.
- 13 Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. (2001) 38 107–125.
- 14 Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. (1994) 330 613–622.
- 15 Johansson B., Georgiev V., Parkinson F.E., Fredholm B.B. The binding of the adenosine A2A receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum. Eur. J. Pharmacol. (1993) 247 103–110.
- 16 Gao Y., Phillis J.W. CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci. (1994) 55 61–65.
- 17 Belcastro V., Tozzi A., Tantucci M. et al. A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity. Exp. Neurol. (2009) 217 231–234.
- 18 Gui L., Duan W., Tian H. et al. Adenosine A2A receptor deficiency reduces striatal glutamate outflow and attenuates brain injury induced by transient focal cerebral ischemia in mice. Brain Res. (2009) 1297 185–193.
- 19 El Yacoubi M., Ledent C., Parmentier M., Daoust M., Costentin J., Vaugeois J. Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice. Neuropharmacology (2001) 40 424–432.
- 20 El Yacoubi M., Ledent C., Parmentier M., Costentin J., Vaugeois J. Adenosine A2A receptor deficient mice are partially resistant to limbic seizures. Naunyn. Schmiedebergs Arch. Pharmacol. (2009) 380 223–232.
- 21 Pintor A., Quarta D., Pezzola A., Reggio R., Popoli P. SCH 58261(an adenosine A2A receptor antagonist) reduces, only at low doses, K+-evoked glutamate release in the striatum. Eur. J. Pharmacol. (2001) 421 177–180.
- 22 Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. (1972) 32 195–299.
- 23 Aebi U., Chiu W., Milligan R. Role of catalase on antioxidative defenses. J. Struct. Biol. (1995) 2 117–118.
- 24 Wendel A. Glutathione peroxidase. Meth. Enzymol. (1981) 77 325–333.
- 25 Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-Transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. (1974) 249 7130–7139.
- 26 Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. (1976) 72 248–254.
- 27 Albala B.J., Moshé S.L., Okada R. Kainic-acid-induced seizures: a developmental study. Brain Res. (1984) 315 139–148.
- 28 Austin J.K., Dunn D.W. Progressive behavioral changes in children with epilepsy. Prog. Brain Res. (2002) 135 419–427.
- 29 McCabe B.K., Silveira D.C., Cilio M.R. et al. Reduced neurogenesis after neonatal seizures. J. Neurosci. (2001) 21 2094–2103.
- 30 Gale K., Proctor M., Velíšková J., Nehlig A. Basal ganglia and brain stem anatomy and physiology, in: J. Engel, T.A. Pedley (Eds), Epilepsy: a comprehensive textbook, Lippincott-Raven, Philadelphia, USA, 2008, pp. 367–384.
- 31 Wei C.J., Li W., Chen J.F. Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim. Biophys. Acta (2010) 1808 1358–1379.
- 32 Jones P.A., Smith R.A., Stone T.W. Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res. (1998) 800 328–335.
- 33 D’Alimonte I., D’Auro M., Citraro R. et al. Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease. Eur. J. Neurosci. (2009) 30 1023–1035.
- 34 Huber A., Güttinger M., Möhler H., Boison D. Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci. Lett. (2002) 329 289–292.
- 35 Adami M., Bertorelli R., Ferri N., Foddi M.C., Ongini E. Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat. Eur. J. Pharmacol. (1995) 294 383–389.
- 36 Zeraati M., Mirnajafi-Zadeh J., Fathollahi Y., Namvar S., Rezvani M.E. Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats. Seizure (2006) 15 41–48.
- 37 Hosseinmardi N., Mirnajafi-Zadeh J., Fathollahi Y., Shahabi P. The role of adenosine A1 and A2A receptors of entorhinal cortex on piriform cortex kindled seizures in rats. Pharmacol. Res. (2007) 56 110–117.
- 38 Sebastião A.M., Ribeiro J.A. Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus. Neurosci. Lett. (1992) 138 41–44.
- 39 Cunha R.A., Johansson B., Fredholm B.B., Ribeiro J.A., Sebastião A.M. Adenosine A2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus. Neurosci. Lett. (1995) 196 41–44.
- 40 Corsi C., Melani A., Bianchi L., Pepeu G., Pedata F. Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats. Neuroreport (1999) 10 687–691.
- 41 Michaelis E.K. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. (1998) 54 369–415.
- 42 Lees G.J. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs (2000) 59 33–78.
- 43 Pedata F., Corsi C., Melani A., Bordoni F., Latini S. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Ann. NY Acad. Sci. (2001) 939 74–78.
- 44 Corsi C., Melani A., Bianchi L., Pedata F. Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. Neuroreport (2000) 11 2591–2595.
- 45 Berman R.F., Fredholm B.B., Aden U., O’Connor W.T. Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats. Brain Res. (2000) 1808 1380–1399.
- 46 Gomes C.V., Kaster M.P., Tomé A.R., Agostinho P.M., Cunha R.A. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim. Biophys. Acta (2010) 1808 1380–1399.
- 47 Sudha K., Rao A.V., Rao A. Oxidative stress and antioxidants in epilepsy. Clin. Chim. Acta (2001) 303 19–24.
- 48 Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic. Biol. Med. (2004) 37 1951–1962.
- 49 Behan W.M., Stone T.W. Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists. Br. J. Pharmacol. (2002) 135 1435–1442.
- 50 Ribé D., Sawbridge D., Thakur S. et al. Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity. Free Radic. Biol. Med. (2008) 44 1433–1442.
- 51 Thakur S., Du J., Hourani S., Ledent C., Li J.M. Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells. J. Biol. Chem. (2010) 285 40104–40113.
- 52 Erakovic V., Zupan G., Varljen J., Laginja J., Smonic A. Lithium plus pilocarpine induced status epilepticus – biochemical changes. Neurosci. Res. (2000) 36 157–166.
- 53 Naffah-Mazzacoratti M.G., Amado D., Cukiert A., Gronich G., Marino R., Calderazzo L. Monoamines and their metabolites in cerebrospinal fluid and temporal cortex of epileptic patients. Epilepsy Res. (1996) 25 133–137.